muramidase and Thrombocytopenia

The discovery of cytosine arabinoside, and then the anthrocycline antibiotics, 6-thioguanine, vincristine, cyclophosphamide, and other drugs, has added to the armamentarium of known effective agents. The use of combination chemotherapy, the recognition of the need during induction for virtual marrow aplasia to obtain a remission, and recognition of the predilection of the disease for the central nervous system requiring prophylaxis constitute major advances. The impediment to long-term survival is the lack of effective maintenance therapy.

Topics: Acute Disease; Adolescent; Agranulocytosis; Antineoplastic Agents; Cells, Cultured; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Graft vs Host Reaction; Hodgkin Disease; Humans; Infections; Leukemia; Leukocytosis; Male; Muramidase; Preleukemia; Thrombocytopenia; Uric Acid

The role of free radical generation and its scavenging enzymes in circulating mice polymorphonuclear leukocytes (PMNLs) has been studied following pulmonary thromboembolism. Levels of malonaldehyde (MDA), 02- radical generation, activity of superoxide dismutase (SOD), catalase (CAT), lactate dehydrogenase (LDH), myeloperoxidase (MPO) and lysozyme were estimated in lysed neutrophil preparations. Activities of SOD and CAT were increased in neutrophils, while animals showed 60 +/- 4% thrombocytopenia. Levels of MDA in PMNLs were also elevated significantly following thrombosis. However, there was no significant change in superoxide radical generation, after thrombotic challenge, in mice neutrophils. The present study provides evidence for the involvement of free radicals in mice pulmonary thromboembolism.

Topics: Animals; Catalase; Collagen; Epinephrine; Free Radical Scavengers; Free Radicals; Leukocyte Count; Lipid Peroxidation; Male; Malondialdehyde; Mice; Muramidase; Neutropenia; Neutrophils; Peroxidase; Pulmonary Embolism; Superoxide Dismutase; Thrombocytopenia

Hen egg white lysozyme (Fleming's lysozyme) prevented the thrombocytopenia provoked by carrageenan injected intravenously into rabbits but not that provoked by an anaphylactic shock. Lysozyme was given intravenously at 25, 50, 100 mg/kg 30 sec before carrageenan. Platelets were counted 15 and 60 min after carrageenan. Lysozyme was given intravenously to immunized animals at the dose of 100 mg/kg 5 min before a challenging dose of the antigens (horse serum-ovalbumin). Platelets were counted 5 min after challenge. The results are discussed in the light of the intervention of platelets and prostaglandins into tumour spread and metastases dissemination.

Topics: Animals; Carrageenan; Muramidase; Neoplasm Metastasis; Platelet Aggregation; Prostaglandins; Rabbits; Thrombocytopenia

Topics: Aged; Anemia; Bone Marrow; Humans; Leukemia, Myeloid; Leukocyte Count; Middle Aged; Mortality; Muramidase; Splenomegaly; Thrombocytopenia

The data on 31 patients who fit into the clinical spectrum of subacute myeloid leukemia have been reviewed. The majority of patients were male with a median age of 61 years. The interval from onset of symptoms to actual diagnosis was extremely variable, with a mean of 16 months and a median of six months. Most patients presented with anemia and thrombocytopenia, although the white blood cell count varied from striking leukopenia to marked leukocytosis. Examination of the bone marrow invariably revealed abnormalities of all cell lines with megaloblastoid erythrogenesis and dysplastic megakaryocytopoiesis. Although the white cell line showed prominence of immature forms, there was more maturation than is seen in acute myeloid leukemia. Survival from diagnosis was variable, from less than one month to greater than 68 months, with a median of only six months. Anemia and hepatosplenomegaly were prognosticators of a poor outlook; patients with hepatosplenomegaly in association with either leukocytosis or thrombocytopenia had a particularly poor outlook, with a median survival of only one and a half months. Approximately half the patients received chemotherapy with no demonstrated effect on survival.

Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Antineoplastic Agents; Blood Cell Count; Bone Marrow Cells; Hematocrit; Humans; Leukemia, Myeloid; Leukocytes; Middle Aged; Muramidase; Prognosis; Thrombocytopenia

Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anemia; Child; Cytarabine; DNA, Neoplasm; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Muramidase; Nausea; Remission, Spontaneous; Sex Factors; Thioguanine; Thrombocytopenia; Time Factors; Vomiting

Topics: Acute Disease; Age Factors; Aged; Agranulocytosis; Anemia; Bone Marrow Examination; Cell Transformation, Neoplastic; Ecchymosis; Erythropoiesis; Female; Hematocrit; Humans; Iron; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Muramidase; Myeloproliferative Disorders; Splenomegaly; Syndrome; Thrombocytopenia

Topics: Adolescent; Adult; Aged; Agranulocytosis; Allopurinol; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Middle Aged; Muramidase; Nausea; Prednisolone; Thrombocytopenia; Vincristine

Topics: Adolescent; Adult; Agranulocytosis; Albinism; Anemia, Hemolytic; Blood Cell Count; Blood Cells; Blood Platelets; Bone Marrow Cells; Child; Etiocholanolone; Hematologic Diseases; Humans; Hypersplenism; Kinetics; Leukocyte Count; Leukocytes; Light; Lymphocytes; Male; Monocytes; Muramidase; Prednisone; Splenomegaly; Thrombocytopenia